Your browser doesn't support javascript.
loading
Pericardial effusion in the course of Fabry disease cardiomyopathy: a case report.
Tsuruda, Toshihiro; Higashi, Yoshimasa; Gi, Toshihiro; Nakao, Shoichiro.
Afiliação
  • Tsuruda T; Department of Internal Medicine, Circulatory and Body Fluid Regulation, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
  • Higashi Y; Department of Internal Medicine, Saigo Hospital, 29 Saigo-Tashiro, Misato, Higashi-Usuki, Miyazaki 883-1101, Japan.
  • Gi T; Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
  • Nakao S; Department of Internal Medicine, Kirishima Memorial Hospital, 1-5-19 Fukushima, Kokubu, Kirishima 899-4322, Japan.
Eur Heart J Case Rep ; 5(10): ytab407, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34729455
ABSTRACT

BACKGROUND:

Fabry disease (FD) is an X-chromosome-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A activity. CASE

SUMMARY:

A 51-year-old Japanese woman with a previous diagnosis of FD presented with pericardial effusion. The exudative pericardial fluid contained globotriaosylsphingosine. Left ventricular hypertrophy progressed despite regular administration of agalsidase alfa every 2 weeks over a 7-year period, with increases in plasma levels of globotriaosylsphingosine and interleukin (IL)-18. In addition, the IL-6 level in the pericardial fluid was markedly higher than that in plasma.

DISCUSSION:

This case suggests that elevated IL-6 and IL-18 levels in pericardial fluid and plasma indicate the severity of FD cardiomyopathy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article